Showing posts with label Schizophrenia. Show all posts
Showing posts with label Schizophrenia. Show all posts

08 February 2010

Study Finds Mental Benefit of Fish Oil

The Wall Street Journal


Fish oil pills may be able to spare some young people with signs of mental illness from a progression into fully developed schizophrenia, according to a preliminary study of 81 patients in Austria.

The study adds to evidence suggesting that severe mental illness may be prevented with intervention. The researchers are starting a larger study in eight cities, hoping to replicate the findings, which appear in the February issue of Archives of General Psychiatry, released Monday.

A severe mental illness, schizophrenia affects adolescents and young adults. Some 2.4 million Americans have the disorder, which is treated with antipsychotic medication.

"Schizophrenia is among the most mysterious and costliest diseases in terms of human suffering, so anything that gives some hope to avoid this is great,'' said lead author Dr. G. Paul Amminger, formerly in Vienna and now at the Orygen Youth Health Research Center at the University of Melbourne in Australia.

Researchers have wondered if the disease could be stopped before it overpowers a person's grip on reality. Studies have tried antipsychotics in select young people, but side effects pose ethical questions, and results have been mixed.

Researchers in the new study identified 81 people, ages 13 to 25, with warning signs of psychosis, including sleeping much more or less than usual, growing suspicious of others, believing someone is putting thoughts in their head or believing they have magical powers. Forty-one were randomly assigned to take four fish oil pills a day for three months. The other patients took dummy pills.

After a year of monitoring, 2 of the 41 patients in the fish oil group, or about 5%, had become psychotic, or completely out of touch with reality. In the placebo group, 11 of 40 became psychotic, about 28%.

No one knows what causes schizophrenia but one hypothesis is that people with the disease don't process fatty acids correctly, leading to damaged brain cells. Omega-3 fatty acids in fish oil could help brain cells repair and stabilize, the researchers speculate.

Dr. Janet Wozniak of Harvard Medical School said the findings might reasonably cause psychiatrists to recommend fish oil to some patients because there are known benefits and little risk.

05 January 2010

Biological Cells Reveal Brain Chemistry Secrets

BBC News

Scientists have developed biological cells that can give insight into the chemistry of the brain.

The cells, which change colour when exposed to specific chemicals, have been used to show how a class of schizophrenia drug works.


The researchers hope they will also help shed light on how many other drugs work on the brain.

The study, by the University of California - San Diego, is published in Nature Neuroscience.

Schizophrenia is most commonly associated with symptoms such as delusions and hallucinations.

But people with the illness also struggle to sustain attention or recall information.

A class of drugs called atypical neuroleptics has become commonly prescribed, in part because they seem to improve these problems.

However, the way they altered brain chemistry was uncertain.

It was known that the drugs trigger the release of a large amount of a chemical called acetylcholine, which enables brain cells to communicate with each other.

However, the drugs have also been shown to hobble a receptor on the surface of the receiving cell, which would effectively block the message.

The San Diego team designed biological cells - called CNiFERs - which changed colour when acetylcholine latched onto this particular class of receptors - an event scientists have not previously been able to detect in a living brain.

They implanted the cells into rat brains, then stimulated a deeper part of the brain in a way known to release acetylcholine nearby.

In response, CNiFERs changed colour - proving that they were working.

They then gave the rats one of two atypical neuroleptics. In both cases the drug severely depressed the response from the CNiFERs.

This suggested that the drugs' receptor-blocking action over-rides the increase they trigger in acetylcholine.

Researcher Professor David Kleinfeld said the new cells had great potential to reveal the mysteries of chemical action in the brain.

He said: "It's a world of signalling between cells that we were blind to before."

The researchers say they are already working to redesign CNiFERS so they can detect the activity of other types of receptors as well.

Paul Corry, of the mental health charity Rethink, said: "This study shows the value of mental health research.

"It is eliciting new information that could lead to the development of more effective drug treatments for schizophrenia, which have fewer of the debilitating side-effects associated with even the most modern atypical medicines.

"That in itself would benefit millions of people around the world.

"But the research also offers a new technique for understanding the workings of the brain that could also be developed for use across broad areas of medicine.

"We really do need to recognise that mental health research is starved of funds compared to other areas of medicine and recognise also that much of it takes place at the frontiers of our understanding which means that results from it could have far-reaching applications."